Home / Journals American Journal of Life Sciences / Sarcoidosis and Lung Cancer
Sarcoidosis and Lung Cancer
Submission DeadlineFeb. 20, 2020

Submission Guidelines: http://www.sciencepublishinggroup.com/home/submission

Lead Guest Editor
Good Samaritan Hospital,SSM Health, Mount Vernon, Illinois, USA
Guest Editors
  • Abdulmonam Ali
    Good Samaritan Hospital,SSM Health, Mount Vernon, Illinois, USA
  • Ravneet Riar
    Good Samaritan Hospital,SSM Health, Mount Vernon, Illinois, USA
  • Ravi Morumuru
    DePaul Hospital, SSM Health, St. Louis, Missouri, USA
Introduction
Sarcoidosis is a commonly seen interstitial lung disease and lung cancer is most the common cancer in smokers. There are several reports published in the past describing some association between sarcoid like reaction (granulomatous inflammation) and lung cancer. It is not clearly known about the causal relationship whether sarcoidosis is coexisting inflammatory reaction in lung cancer or a risk factor for development of lung cancer. The issue will cover all the research and case reports published in relation to sarcoidosis in association with lung cancer.
Aims and Scope:
  1. Sarcoidosis
  2. Non-caseating granulomatous inflammation
  3. Non-small cell lung cancer
  4. Small cell lung cancer
  5. Lung nodules
  6. Bronchogenic malignancy
Guidelines for Submission
Manuscripts should be formatted according to the guidelines for authors
(see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=118).

Please download the template to format your manuscript.

ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186